Can two diabetes pills beat one? new study tests early combo therapy

NCT ID NCT06613854

Recruiting now Disease control Sponsor: University Medical Centre Ljubljana Source: ClinicalTrials.gov ↗

First seen May 03, 2026 · Last updated May 21, 2026 · Updated 6 times

Summary

This study tests whether starting two diabetes drugs early—metformin plus either oral semaglutide or empagliflozin—works better than metformin alone for controlling blood sugar in people recently diagnosed with type 2 diabetes. About 90 adults with diabetes for up to 2 years will take the assigned pills daily for 26 weeks and wear a continuous glucose monitor. The goal is to see if the combination improves blood sugar levels, weight, and overall health without added safety risks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

University Medical Centre Ljubljana, Diabetes Outpatient Clinic
RECRUITING

Ljubljana, 1000, Slovenia

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact

Conditions

Explore the condition pages connected to this study.

TYPE 2 DIABETES MELLITUS (T2DM)